Latest Didanosine Stories

2014-07-01 16:25:46

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Bristol-Myers Squibb Company - Product Pipeline Review - 2014http://www.reportbuyer.com/pharma_healthcare/therapeutic/bristol_myers_squibb_company_product_pipeline_review_2013.html Bristol-Myers Squibb Company - Product Pipeline Review - 2014 SummaryGlobal Markets Direct's, 'Bristol-Myers Squibb Company - Product Pipeline Review - 2014', provides an overview of the Bristol-Myers Squibb...

2014-04-15 12:30:09

PITTSBURGH, April 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that it and its partner Famy Care Ltd. have entered into a settlement and license agreement with Warner Chilcott Company, LLC, settling the parties' litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Norethindrone and Ethinyl Estradiol Chewable Tablets 0.8 mg/0.025 mg and Ferrous Fumarate Chewable Tablets. This...

2014-03-25 00:23:18

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rq8jml/investigation) has announced the addition of the "Investigation Report on China Montelukast Market" [http://www.researchandmarkets.com/research/rq8jml/investigation ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) There are over 30 million people suffering from seasonal asthma of different...

FDA Approves Novel AstraZeneca, Bristol-Meyers Squibb Diabetes Drug
2014-01-10 11:37:58

Ranjini Raghunath for redOrbit.com - Your Universe Online The FDA has approved the use of a new Type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca. Type 2 diabetes affects 24 million people in the US and nearly 350 million people worldwide. Conventional diabetes drugs work by reducing the amount of sugar the body absorbs from food or by boosting the production of insulin which disposes of excess sugar. Farxiga, however,...

2013-08-01 23:22:36

The CAI prioritized the NCI portfolio resulting in 50 near-term commercially viable inventions. The CAI will coordinate with small businesses, the biopharmaceutical industry and educational institutions to match these NCI technologies for possible collaboration and technology transfer. Bethesda, Maryland (PRWEB) August 01, 2013 The Center for Advancing Innovation, INC (CAI), a globally focused private-public partnership with an over-arching mission to drive successful innovation entered...

Word of the Day
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'